284 related articles for article (PubMed ID: 30627867)
41. Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.
D'Addio SM; Reddy VM; Liu Y; Sinko PJ; Einck L; Prud'homme RK
Mol Pharm; 2015 May; 12(5):1554-63. PubMed ID: 25811733
[TBL] [Abstract][Full Text] [Related]
42. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
43. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
Wang F; Yang S; Yuan J; Gao Q; Huang C
J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
[TBL] [Abstract][Full Text] [Related]
44. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages.
Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A
Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.
Garcia-Contreras L; Sethuraman V; Kazantseva M; Godfrey V; Hickey AJ
J Antimicrob Chemother; 2006 Nov; 58(5):980-6. PubMed ID: 16971416
[TBL] [Abstract][Full Text] [Related]
46. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
[TBL] [Abstract][Full Text] [Related]
47. Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis.
Turco BO; Boni FI; Gremião MPD; Chorilli M
Drug Dev Ind Pharm; 2021 Dec; 47(12):1904-1914. PubMed ID: 35236214
[TBL] [Abstract][Full Text] [Related]
48. Preparation and cytotoxicity of N,N,N-trimethyl chitosan/alginate beads containing gold nanoparticles.
Martins AF; Facchi SP; Monteiro JP; Nocchi SR; Silva CT; Nakamura CV; Girotto EM; Rubira AF; Muniz EC
Int J Biol Macromol; 2015 Jan; 72():466-71. PubMed ID: 25159881
[TBL] [Abstract][Full Text] [Related]
49. Preparation of Curdlan sulphate - Chitosan nanoparticles as a drug carrier to target Mycobacterium smegmatis infected macrophages.
Ravindran R; Mitra K; Arumugam SK; Doble M
Carbohydr Polym; 2021 Apr; 258():117686. PubMed ID: 33593559
[TBL] [Abstract][Full Text] [Related]
50. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
Sheng Y; He H; Zou H
Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
[TBL] [Abstract][Full Text] [Related]
51. Delivery of rifampicin-chitin nanoparticles into the intracellular compartment of polymorphonuclear leukocytes.
Smitha KT; Nisha N; Maya S; Biswas R; Jayakumar R
Int J Biol Macromol; 2015 Mar; 74():36-43. PubMed ID: 25475841
[TBL] [Abstract][Full Text] [Related]
52. [Preparation, characterization, and pulmonary delivery of rifapentine liposomes modified by lauric diethanolamide].
Shu JY; Quan XY; Shu Y; Guang YP; Liu YC
Yao Xue Xue Bao; 2006 Aug; 41(8):761-4. PubMed ID: 17039784
[TBL] [Abstract][Full Text] [Related]
53. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice.
Liang Q; Xiang H; Li X; Luo C; Ma X; Zhao W; Chen J; Tian Z; Li X; Song X
Int J Nanomedicine; 2020; 15():7491-7507. PubMed ID: 33116484
[TBL] [Abstract][Full Text] [Related]
54. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
[TBL] [Abstract][Full Text] [Related]
55. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.
Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764
[TBL] [Abstract][Full Text] [Related]
56. Comparative evaluation of polymeric nanoparticles of rifampicin comprising Gantrez and poly(ethylene sebacate) on pharmacokinetics, biodistribution and lung uptake following oral administration.
Patel MD; Date PV; Gaikwad RV; Samad A; Malshe VC; Devarajan PV
J Biomed Nanotechnol; 2014 Apr; 10(4):687-94. PubMed ID: 24734521
[TBL] [Abstract][Full Text] [Related]
57. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
58. Conjugated and Entrapped HPMA-PLA Nano-Polymeric Micelles Based Dual Delivery of First Line Anti TB Drugs: Improved and Safe Drug Delivery against Sensitive and Resistant Mycobacterium Tuberculosis.
Upadhyay S; Khan I; Gothwal A; Pachouri PK; Bhaskar N; Gupta UD; Chauhan DS; Gupta U
Pharm Res; 2017 Sep; 34(9):1944-1955. PubMed ID: 28685299
[TBL] [Abstract][Full Text] [Related]
59. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
60. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH
Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
